CD36 and atherosclerosis: Cluster of differentiation 36 (CD36), a crucial receptor for long-chain fatty acid uptake and lipid metabolism [21,22], has emerged as a therapeutic target for a range of lipid metabolism-related disorders, such as non-alcoholic fatty liver disease [23], atherosclerosis [24], and diabetic nephropathy [25].